Evicenter
Otezla (apremilast) in Plaque psoriasis
Manufacturer
Amgen Inc.
Prescribing information
Otezla (opens in a new tab)
Questions
27
Last updated

All questions

Clinical trials: Otezla (apremilast) in plaque psoriasis

8 questions · 6 sources

Study results

How effective is Otezla vs placebo for moderate to severe plaque psoriasis at 16 weeks?

Applies to Moderate to severe plaque psoriasis in adults who are candidates for phototherapy or systemic therapy (ESTEEM 1 and ESTEEM 2; PSOR-1 and PSOR-2 in the label)

Note: The Otezla HCP site names the trials ESTEEM 1 (N=844) and ESTEEM 2 (N=413); the Prescribing Information names the same enrollments PSOR-1 and PSOR-2. Table 8 columns are placebo and OTEZLA 30 mg twice daily for PSOR-1, then placebo and OTEZLA 30 mg twice daily for PSOR-2.

How were the Otezla ESTEEM plaque psoriasis trials designed?

Applies to Moderate to severe plaque psoriasis in adults who are candidates for phototherapy or systemic therapy (ESTEEM 1 and ESTEEM 2; PSOR-1 and PSOR-2 in the label)

Does Otezla work for mild to moderate plaque psoriasis vs placebo (ADVANCE)?

Applies to Mild to moderate plaque psoriasis in adults with an inadequate response or intolerance to topical therapy (ADVANCE; PSOR-4 in the label)

Note: The Otezla HCP site names the trial ADVANCE; the Prescribing Information names it PSOR-4 (595 adults randomized to OTEZLA 30 mg twice daily or placebo).

Does Otezla relieve plaque psoriasis itch vs placebo at 16 weeks?

Applies to Plaque psoriasis in adults who are candidates for phototherapy or systemic therapy

Note: Columns in both tables are placebo, OTEZLA 30 mg twice daily, and the treatment difference with its 95% CI. Trial PSOR-4 (ADVANCE on the Otezla HCP site) enrolled adults with mild to moderate plaque psoriasis; Trial PSOR-3 (STYLE) enrolled adults with moderate to severe plaque psoriasis of the scalp. Both itch responses are a reduction of at least 4 points from baseline, among subjects with a baseline score of at least 4.

How effective is Otezla vs placebo for moderate to severe scalp psoriasis (STYLE)?

Applies to Moderate to severe plaque psoriasis of the scalp in adults (STYLE; PSOR-3 in the label)

Note: The Otezla HCP site names the trial STYLE; the Prescribing Information names it PSOR-3. Table 9 columns are placebo, OTEZLA 30 mg twice daily, and the treatment difference with its 95% CI.

How effective is Otezla vs placebo for children with plaque psoriasis (SPROUT)?

Applies to Moderate to severe plaque psoriasis in pediatric patients 6 years of age and older who are candidates for phototherapy or systemic therapy and weigh at least 20 kg (OTEZLA) or at least 50 kg (OTEZLA XR)

Note: Table 11 columns are placebo, OTEZLA, and the treatment difference with its 95% CI. The Prescribing Information names the trial PSOR-6; the Otezla HCP site names it SPROUT.

Clinical trials

How many adults were in the Otezla ESTEEM and ADVANCE psoriasis trials?

Applies to Plaque psoriasis in adults who are candidates for phototherapy or systemic therapy

Which clinical trials studied Otezla for plaque psoriasis?

Note: The FAQ answer also lists trials in psoriatic arthritis and Behcet's disease, which are not quoted.